Hanover - Delayed Quote EUR

Biomarin Pharmaceutical Inc (BM8.HA)

Compare
62.18 -1.60 (-2.51%)
As of 8:01:11 AM GMT+1. Market Open.
Loading Chart for BM8.HA
DELL
  • Previous Close 63.78
  • Open 62.18
  • Bid 62.56 x --
  • Ask 62.74 x --
  • Day's Range 62.18 - 62.18
  • 52 Week Range 58.00 - 90.10
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 20, 2025 - Feb 24, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: BM8.HA

View More

Performance Overview: BM8.HA

Trailing total returns as of 12/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BM8.HA
28.99%
S&P 500
24.39%

1-Year Return

BM8.HA
30.09%
S&P 500
25.16%

3-Year Return

BM8.HA
15.38%
S&P 500
28.40%

5-Year Return

BM8.HA
5.50%
S&P 500
85.92%

Compare To: BM8.HA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BM8.HA

View More

Valuation Measures

Annual
As of 12/18/2024
  • Market Cap

    11.75B

  • Enterprise Value

    11.44B

  • Trailing P/E

    40.32

  • Forward P/E

    17.33

  • PEG Ratio (5yr expected)

    0.42

  • Price/Sales (ttm)

    4.69

  • Price/Book (mrq)

    2.36

  • Enterprise Value/Revenue

    4.36

  • Enterprise Value/EBITDA

    23.67

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: BM8.HA

View More

Company Insights: BM8.HA

Research Reports: BM8.HA

View More